203 related articles for article (PubMed ID: 31090790)
1. Hepcidin is a useful biomarker to evaluate hyperferritinemia associated with metabolic syndrome.
Rauber MR; Pilger DA; Cecconello DK; Falcetta FS; Marcondes NA; Faulhaber GAM
An Acad Bras Cienc; 2019 May; 91(2):e20180286. PubMed ID: 31090790
[TBL] [Abstract][Full Text] [Related]
2. Correlates of hepcidin and NTBI according to HFE status in patients referred to a liver centre.
Ryan E; Ryan JD; Russell J; Coughlan B; Tjalsma H; Swinkels DW; Stewart S; Crowe JP
Acta Haematol; 2015; 133(2):155-61. PubMed ID: 25277871
[TBL] [Abstract][Full Text] [Related]
3. Dysmetabolic hyperferritinemia is associated with normal transferrin saturation, mild hepatic iron overload, and elevated hepcidin.
Chen LY; Chang SD; Sreenivasan GM; Tsang PW; Broady RC; Li CH; Zypchen LN
Ann Hematol; 2011 Feb; 90(2):139-43. PubMed ID: 20721554
[TBL] [Abstract][Full Text] [Related]
4. Hepcidin resistance in dysmetabolic iron overload.
Rametta R; Dongiovanni P; Pelusi S; Francione P; Iuculano F; Borroni V; Fatta E; Castagna A; Girelli D; Fargion S; Valenti L
Liver Int; 2016 Oct; 36(10):1540-8. PubMed ID: 26998752
[TBL] [Abstract][Full Text] [Related]
5. Hyperferritinemia, iron overload, and multiple metabolic alterations identify patients at risk for nonalcoholic steatohepatitis.
Fargion S; Mattioli M; Fracanzani AL; Sampietro M; Tavazzi D; Fociani P; Taioli E; Valenti L; Fiorelli G
Am J Gastroenterol; 2001 Aug; 96(8):2448-55. PubMed ID: 11513189
[TBL] [Abstract][Full Text] [Related]
6. Increased serum hepcidin levels in subjects with the metabolic syndrome: a population study.
Martinelli N; Traglia M; Campostrini N; Biino G; Corbella M; Sala C; Busti F; Masciullo C; Manna D; Previtali S; Castagna A; Pistis G; Olivieri O; Toniolo D; Camaschella C; Girelli D
PLoS One; 2012; 7(10):e48250. PubMed ID: 23144745
[TBL] [Abstract][Full Text] [Related]
7. Hyperferritinemia and iron metabolism in Gaucher disease: Potential pathophysiological implications.
Regenboog M; van Kuilenburg AB; Verheij J; Swinkels DW; Hollak CE
Blood Rev; 2016 Nov; 30(6):431-437. PubMed ID: 27265538
[TBL] [Abstract][Full Text] [Related]
8. Mass spectrometry measurement of plasma hepcidin for the prediction of iron overload.
Floreani A; Navaglia F; Rizzotto ER; Basso D; Chiaramonte M; Padoan A; Petridis I; Cazzagon N; Testa R; Marra M; Plebani M
Clin Chem Lab Med; 2011 Feb; 49(2):197-206. PubMed ID: 21143008
[TBL] [Abstract][Full Text] [Related]
9. Blunted increase in serum hepcidin as response to oral iron in HFE-hemochromatosis.
Sangwaiya A; Manglam V; Busbridge M; Thursz M; Arnold J
Eur J Gastroenterol Hepatol; 2011 Aug; 23(8):721-4. PubMed ID: 21654321
[TBL] [Abstract][Full Text] [Related]
10. Non-invasive methods for iron overload evaluation in dysmetabolic patients.
Branisso PPF; de Oliveira CPMS; Filho HML; Lima FR; Santos AS; Mancini MC; de Melo ME; Carrilho FJ; Rocha MS; Clark P; Branisso HJP; Cercato C
Ann Hepatol; 2022; 27(4):100707. PubMed ID: 35477031
[TBL] [Abstract][Full Text] [Related]
11. Hemochromatosis and iron-overload screening in a racially diverse population.
Adams PC; Reboussin DM; Barton JC; McLaren CE; Eckfeldt JH; McLaren GD; Dawkins FW; Acton RT; Harris EL; Gordeuk VR; Leiendecker-Foster C; Speechley M; Snively BM; Holup JL; Thomson E; Sholinsky P;
N Engl J Med; 2005 Apr; 352(17):1769-78. PubMed ID: 15858186
[TBL] [Abstract][Full Text] [Related]
12. Higher ferritin levels, but not serum iron or transferrin saturation, are associated with Type 2 diabetes mellitus in adult men and women free of genetic haemochromatosis.
Yeap BB; Divitini ML; Gunton JE; Olynyk JK; Beilby JP; McQuillan B; Hung J; Knuiman MW
Clin Endocrinol (Oxf); 2015 Apr; 82(4):525-32. PubMed ID: 24953981
[TBL] [Abstract][Full Text] [Related]
13. Measurement of serum hepcidin-25 levels as a potential test for diagnosing hemochromatosis and related disorders.
Kaneko Y; Miyajima H; Piperno A; Tomosugi N; Hayashi H; Morotomi N; Tsuchida K; Ikeda T; Ishikawa A; Ota Y; Wakusawa S; Yoshioka K; Kono S; Pelucchi S; Hattori A; Tatsumi Y; Okada T; Yamagishi M
J Gastroenterol; 2010 Nov; 45(11):1163-71. PubMed ID: 20533066
[TBL] [Abstract][Full Text] [Related]
14. Relationship of serum haemojuvelin and hepcidin levels with iron level and erythropoietin requirement in prevalent hepatitis C virus positive haemodialysis patients.
El Said HW; Abou Seif KH; Ahmed YS; Abou Elleil HA; El Said TW; Behairy MA; Mohamed MM; Ahmed FA
Nephrology (Carlton); 2018 Apr; 23(4):323-330. PubMed ID: 28130911
[TBL] [Abstract][Full Text] [Related]
15. Predicting iron overload in hyperferritinemia.
Olynyk JK; Gan E; Tan T
Clin Gastroenterol Hepatol; 2009 Mar; 7(3):359-62. PubMed ID: 19095082
[TBL] [Abstract][Full Text] [Related]
16. Screening selected blood donors with biochemical iron overload for hemochromatosis: a regional experience.
De Gobbi M; D'Antico S; Castagno F; Testa D; Merlini R; Bondi A; Camaschella C
Haematologica; 2004 Oct; 89(10):1161-7. PubMed ID: 15477198
[TBL] [Abstract][Full Text] [Related]
17. Iron overload in congenital haemolytic anaemias: role of hepcidin and cytokines and predictive value of ferritin and transferrin saturation.
Barcellini W; Zaninoni A; Gregorini AI; Soverini G; Duca L; Fattizzo B; Giannotta JA; Pedrotti P; Vercellati C; Marcello AP; Fermo E; Bianchi P; Cappellini MD
Br J Haematol; 2019 May; 185(3):523-531. PubMed ID: 30828802
[TBL] [Abstract][Full Text] [Related]
18. Hyperferritinemia is associated with insulin resistance and fatty liver in patients without iron overload.
Brudevold R; Hole T; Hammerstrøm J
PLoS One; 2008; 3(10):e3547. PubMed ID: 18958176
[TBL] [Abstract][Full Text] [Related]
19. Iron Stores, Hepcidin, and Aortic Stiffness in Individuals with Hypertension.
Valenti L; Maloberti A; Signorini S; Milano M; Cesana F; Cappellini F; Dongiovanni P; Porzio M; Soriano F; Brambilla M; Cesana G; Brambilla P; Giannattasio C; Fargion S
PLoS One; 2015; 10(8):e0134635. PubMed ID: 26244503
[TBL] [Abstract][Full Text] [Related]
20. Serum Hepcidin as a Diagnostic Marker of Severe Iron Overload in Beta-thalassemia Major.
Kaddah AM; Abdel-Salam A; Farhan MS; Ragab R
Indian J Pediatr; 2017 Oct; 84(10):745-750. PubMed ID: 28600663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
